Aclaris Therapeutics, Inc. - Common Stock (ACRS)

Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for dermatological and immunological diseases

The company is committed to addressing unmet medical needs by leveraging its expertise in drug development and dermatology to create novel treatment options. Aclaris's research portfolio includes a range of potential therapies aimed at conditions such as alopecia areata and other skin disorders, utilizing both small molecules and biologics to enhance patient care and improve quality of life. Through its dedication to scientific advancement and patient-centered approaches, Aclaris strives to make a meaningful impact in the field of dermatology.